Head to head comparison of adverse effects and efficacy between high dose deflazacort and high dose prednisolone in systemic lupus erythematosus: a prospective cohort study-Reference-Cited by-同舟云学术

Head to head comparison of adverse effects and efficacy between high dose deflazacort and high dose prednisolone in systemic lupus erythematosus: a prospective cohort study

Published:2018-01-10 Issue:6 Volume:27 Page:890-898
ISSN:0961-2033
Container-title:Lupus
language:en
Short-container-title:Lupus

Author:

Ganapati A¹,Ravindran R¹,David T²,Yadav B³,Jeyaseelan V³,Jeyaseelan L³,Danda D¹

Affiliation:

1. Department of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, India

2. Department of Medicine II, Christian Medical College, Vellore, India

3. Department of Biostatistics, Christian Medical College, Vellore, India

Publisher

SAGE Publications

Subject

Rheumatology

Link

http://journals.sagepub.com/doi/pdf/10.1177/0961203317751854

Reference19 articles.

1. Potency Ratio--A Brief Synopsis

2. Serum osteocalcin (bone Gla-protein) following corticosteroid therapy in postmenopausal women with rheumatoid arthritis. Comparison of the effect of prednisone and deflazacort

3. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: A double-blind study on the high-dose, long-term effects of prednisone versus deflazacort

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deflazacort in rheumatoid arthritis: A scoping review;Revista Colombiana de Reumatología (English Edition);2024-01

2. Metabolic adverse events associated with systemic corticosteroid therapy—a systematic review and meta-analysis;BMJ Open;2022-12

3. Deflazacort en artritis reumatoide: revisión panorámica de la literatura (scoping review);Revista Colombiana de Reumatología;2022-05

4. Principles and Guidelines of Immunotherapy in Neuromuscular Disorders;Neuromuscular Disorders;2022

5. Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy Boys;Journal of Personalized Medicine;2020-10-12